APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coagulation Factor XI

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coagulation Factor XI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025188 pages

Choose your research edition.

Industry ResearchCoagulation Factor XI Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Coagulation Factor XI Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Coagulation Factor XI Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coagulation Factor XI Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Coagulation Factor XI Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Coagulation Factor XI market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coagulation Factor XI is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coagulation Factor XI include Bristol-Myers Squibb Company, Cambryn Biologics LLC, eXithera Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc., LegoChem Biosciences, Inc and Bayer AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Coagulation Factor XI market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coagulation Factor XI and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coagulation Factor XI revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Coagulation Factor XI market size, projected growth trends, production technologies, key applications, and end-use industries.

Coagulation Factor XI Segment by Company

Bristol-Myers Squibb Company

Cambryn Biologics LLC

eXithera Pharmaceuticals, Inc

Ionis Pharmaceuticals, Inc.

LegoChem Biosciences, Inc

Bayer AG

Coagulation Factor XI Segment by Type

MR-1007

IONIS-FXIRx

EP-7041

BMS-262084

AB-022

Others

Coagulation Factor XI Segment by Application

Thrombosis

Acute Ischemic Stroke

Bleeding and Clotting Disorders

Others

Coagulation Factor XI Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coagulation Factor XI market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coagulation Factor XI and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coagulation Factor XI.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Coagulation Factor XI in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Coagulation Factor XI industry.

Chapter 3: Detailed analysis of Coagulation Factor XI companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Coagulation Factor XIrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Coagulation Factor XI Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of MR-1007 Table 3. Key Players of IONIS-FXIRx Table 4. Key Players of EP-7041 Table 3. Key Players of BMS-262084 Table 4. Key Players of AB-022 Table 5. Key Players of Others Table 6. Global Coagulation Factor XI Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of Thrombosis Table 8. Key Players of Acute Ischemic Stroke Table 9. Key Players of Bleeding and Clotting Disorders Table 10. Key Players of Others Table 11. Global Coagulation Factor XI Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Coagulation Factor XI Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Coagulation Factor XI Market Share by Region (2021-2026) Table 14. Global Coagulation Factor XI Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Coagulation Factor XI Market Share by Region (2027-2032) Table 16. Coagulation Factor XI Industry Trends Table 17. Coagulation Factor XI Industry Drivers Table 18. Coagulation Factor XI Industry Opportunities and Challenges Table 19. Coagulation Factor XI Industry Restraints Table 20. Global Coagulation Factor XI Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Coagulation Factor XI Revenue Market Share by Company (2021-2026) Table 22. Global Coagulation Factor XI Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Coagulation Factor XI Key Company Head Office and Area Served Table 24. Global Coagulation Factor XI Company, Product Type & Application Table 25. Global Coagulation Factor XI Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Coagulation Factor XI by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Coagulation Factor XI Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Coagulation Factor XI Revenue Market Share by Type (2021-2026) Table 32. Global Coagulation Factor XI Revenue Market Share by Type (2027-2032) Table 33. Global Coagulation Factor XI Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Coagulation Factor XI Revenue Market Share by Application (2021-2026) Table 37. Global Coagulation Factor XI Revenue Market Share by Application (2027-2032) Table 38. Bristol-Myers Squibb Company Company Information Table 39. Bristol-Myers Squibb Company Business Overview Table 40. Bristol-Myers Squibb Company Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio Table 42. Bristol-Myers Squibb Company Recent Development Table 43. Cambryn Biologics LLC Company Information Table 44. Cambryn Biologics LLC Business Overview Table 45. Cambryn Biologics LLC Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Cambryn Biologics LLC Coagulation Factor XI Product Portfolio Table 47. Cambryn Biologics LLC Recent Development Table 48. eXithera Pharmaceuticals, Inc Company Information Table 49. eXithera Pharmaceuticals, Inc Business Overview Table 50. eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio Table 52. eXithera Pharmaceuticals, Inc Recent Development Table 53. Ionis Pharmaceuticals, Inc. Company Information Table 54. Ionis Pharmaceuticals, Inc. Business Overview Table 55. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio Table 57. Ionis Pharmaceuticals, Inc. Recent Development Table 58. LegoChem Biosciences, Inc Company Information Table 59. LegoChem Biosciences, Inc Business Overview Table 60. LegoChem Biosciences, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio Table 62. LegoChem Biosciences, Inc Recent Development Table 63. Bayer AG Company Information Table 64. Bayer AG Business Overview Table 65. Bayer AG Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Bayer AG Coagulation Factor XI Product Portfolio Table 67. Bayer AG Recent Development Table 68. North America Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 69. North America Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 70. North America Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 71. North America Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 72. North America Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 73. North America Coagulation Factor XI Market Size by Country (2021-2026) Table 74. North America Coagulation Factor XI Market Size by Country (2027-2032) Table 75. Europe Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 76. Europe Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 77. Europe Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 78. Europe Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 79. Europe Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. Europe Coagulation Factor XI Market Size by Country (2021-2026) Table 81. Europe Coagulation Factor XI Market Size by Country (2027-2032) Table 82. China Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 83. China Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 84. China Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 85. China Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 86. Asia Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 87. Asia Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 88. Asia Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 89. Asia Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 90. Asia Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. Asia Coagulation Factor XI Market Size by Country (2021-2026) Table 92. Asia Coagulation Factor XI Market Size by Country (2027-2032) Table 93. South America, Middle East & Africa Coagulation Factor XI Market Size by Type (2021-2026) & (US$ Million) Table 94. South America, Middle East & Africa Coagulation Factor XI Market Size by Type (2027-2032) & (US$ Million) Table 95. South America, Middle East & Africa Coagulation Factor XI Market Size by Application (2021-2026) & (US$ Million) Table 96. South America, Middle East & Africa Coagulation Factor XI Market Size by Application (2027-2032) & (US$ Million) Table 97. South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2021-2026) Table 99. South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2027-2032) Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Coagulation Factor XI Product Image Figure 2. Global Coagulation Factor XI Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Coagulation Factor XI Market Share by Type: 2025 VS 2032 Figure 4. MR-1007 Image Figure 5. IONIS-FXIRx Image Figure 6. EP-7041 Image Figure 7. BMS-262084 Image Figure 8. AB-022 Image Figure 9. Others Image Figure 10. Global Coagulation Factor XI Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Coagulation Factor XI Market Share by Application: 2025 VS 2032 Figure 12. Thrombosis Image Figure 13. Acute Ischemic Stroke Image Figure 14. Bleeding and Clotting Disorders Image Figure 15. Others Image Figure 16. Global Coagulation Factor XI Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 18. Global Coagulation Factor XI Market Share by Region: 2025 VS 2032 Figure 19. Years Considered Figure 20. Global Coagulation Factor XI Market Share by Players in 2025 Figure 21. Global Top 5 and 10 Coagulation Factor XI Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Coagulation Factor XI Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Coagulation Factor XI Revenue Market Share by Type (2021-2032) Figure 25. Global Coagulation Factor XI Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Coagulation Factor XI Revenue Market Share by Application (2021-2032) Figure 27. North America Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 28. North America Coagulation Factor XI Market Share by Type (2021-2032) Figure 29. North America Coagulation Factor XI Market Share by Application (2021-2032) Figure 30. North America Coagulation Factor XI Market Share by Country (2021-2032) Figure 31. United States Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 32. Canada Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 33. Mexico Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 34. Europe Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 35. Europe Coagulation Factor XI Market Share by Type (2021-2032) Figure 36. Europe Coagulation Factor XI Market Share by Application (2021-2032) Figure 37. Europe Coagulation Factor XI Market Share by Country (2021-2032) Figure 38. Germany Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 39. France Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 40. U.K. Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 41. Italy Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 42. Russia Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 43. Nordic Countries Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 44. China Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 45. China Coagulation Factor XI Market Share by Type (2021-2032) Figure 46. China Coagulation Factor XI Market Share by Application (2021-2032) Figure 47. Asia Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 48. Asia Coagulation Factor XI Market Share by Type (2021-2032) Figure 49. Asia Coagulation Factor XI Market Share by Application (2021-2032) Figure 50. Asia Coagulation Factor XI Market Share by Country (2021-2032) Figure 51. Japan Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 52. South Korea Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 53. Taiwan Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 54. Southeast Asia Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 55. India Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 56. Australia Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa Coagulation Factor XI Market Share by Type (2021-2032) Figure 59. South America, Middle East & Africa Coagulation Factor XI Market Share by Application (2021-2032) Figure 60. South America, Middle East & Africa Coagulation Factor XI Market Share by Country (2021-2032) Figure 61. Brazil Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 62. South Africa Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 63. Saudi Arabia Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 64. Turkey Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 65. Argentina Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 66. UAE Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 67. Egypt Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 68. Chile Coagulation Factor XI Market Size (2021-2032) & (US$ Million) Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • MR-1007
  • IONIS-FXIRx
  • EP-7041
  • BMS-262084
  • AB-022
  • Others
Applications
  • Thrombosis
  • Acute Ischemic Stroke
  • Bleeding and Clotting Disorders
  • Others
Companies covered
  • Bristol-Myers Squibb Company
  • Cambryn Biologics LLC
  • eXithera Pharmaceuticals, Inc
  • Ionis Pharmaceuticals, Inc.
  • LegoChem Biosciences, Inc
  • Bayer AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Coagulation Factor XI Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 MR-1007
  5. 1.2.3 IONIS-FXIRx
  6. 1.2.4 EP-7041
  7. 1.2.5 BMS-262084
  8. 1.2.6 AB-022
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Coagulation Factor XI Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 Thrombosis
  13. 1.3.3 Acute Ischemic Stroke
  14. 1.3.4 Bleeding and Clotting Disorders
  15. 1.3.5 Others
  16. 1.4 Global Market Growth Prospects
  17. 1.5 Global Coagulation Factor XI Growth Trends by Region
  18. 1.5.1 Global Coagulation Factor XI Market Size by Region: 2021 VS 2025 VS 2032
  19. 1.5.2 Coagulation Factor XI Market Size by Region (2021-2026)
  20. 1.5.3 Coagulation Factor XI Market Size by Region (2027-2032)
  21. 1.6 Assumptions and Limitations
  22. 1.7 Study Goals and Objectives
  23. 1.8 Years Considered
2 Global Coagulation Factor XI Market Dynamics
  1. 2.1 Coagulation Factor XI Industry Trends
  2. 2.2 Coagulation Factor XI Industry Drivers
  3. 2.3 Coagulation Factor XI Industry Opportunities and Challenges
  4. 2.4 Coagulation Factor XI Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Coagulation Factor XI Revenue by Company (2021-2026)
  2. 3.2 Global Coagulation Factor XI Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Coagulation Factor XI Key Company Head office and Area Served
  4. 3.4 Global Coagulation Factor XI Company, Product Type & Application
  5. 3.5 Global Coagulation Factor XI Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Coagulation Factor XI Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Coagulation Factor XI Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Coagulation Factor XI Tier 1, Tier 2, and Tier 3
4 Coagulation Factor XI Market by Type
  1. 4.1 Global Coagulation Factor XI Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Coagulation Factor XI Market Size by Type (2021-2032)
  3. 4.3 Global Coagulation Factor XI Market Size Share by Type (2021-2032)
5 Coagulation Factor XI Market by Application
  1. 5.1 Global Coagulation Factor XI Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Coagulation Factor XI Market Size by Application (2021-2032)
  3. 5.3 Global Coagulation Factor XI Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Bristol-Myers Squibb Company
  2. 6.1.1 Bristol-Myers Squibb Company Company Information
  3. 6.1.2 Bristol-Myers Squibb Company Business Overview
  4. 6.1.3 Bristol-Myers Squibb Company Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Bristol-Myers Squibb Company Coagulation Factor XI Product Portfolio
  6. 6.1.5 Bristol-Myers Squibb Company Recent Developments
  7. 6.2 Cambryn Biologics LLC
  8. 6.2.1 Cambryn Biologics LLC Company Information
  9. 6.2.2 Cambryn Biologics LLC Business Overview
  10. 6.2.3 Cambryn Biologics LLC Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Cambryn Biologics LLC Coagulation Factor XI Product Portfolio
  12. 6.2.5 Cambryn Biologics LLC Recent Developments
  13. 6.3 eXithera Pharmaceuticals, Inc
  14. 6.3.1 eXithera Pharmaceuticals, Inc Company Information
  15. 6.3.2 eXithera Pharmaceuticals, Inc Business Overview
  16. 6.3.3 eXithera Pharmaceuticals, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 eXithera Pharmaceuticals, Inc Coagulation Factor XI Product Portfolio
  18. 6.3.5 eXithera Pharmaceuticals, Inc Recent Developments
  19. 6.4 Ionis Pharmaceuticals, Inc.
  20. 6.4.1 Ionis Pharmaceuticals, Inc. Company Information
  21. 6.4.2 Ionis Pharmaceuticals, Inc. Business Overview
  22. 6.4.3 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Ionis Pharmaceuticals, Inc. Coagulation Factor XI Product Portfolio
  24. 6.4.5 Ionis Pharmaceuticals, Inc. Recent Developments
  25. 6.5 LegoChem Biosciences, Inc
  26. 6.5.1 LegoChem Biosciences, Inc Company Information
  27. 6.5.2 LegoChem Biosciences, Inc Business Overview
  28. 6.5.3 LegoChem Biosciences, Inc Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 LegoChem Biosciences, Inc Coagulation Factor XI Product Portfolio
  30. 6.5.5 LegoChem Biosciences, Inc Recent Developments
  31. 6.6 Bayer AG
  32. 6.6.1 Bayer AG Company Information
  33. 6.6.2 Bayer AG Business Overview
  34. 6.6.3 Bayer AG Coagulation Factor XI Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bayer AG Coagulation Factor XI Product Portfolio
  36. 6.6.5 Bayer AG Recent Developments
7 North America
  1. 7.1 North America Coagulation Factor XI Market Size (2021-2032)
  2. 7.2 North America Coagulation Factor XI Market Size by Type
  3. 7.2.1 North America Coagulation Factor XI Market Size by Type (2021-2026)
  4. 7.2.2 North America Coagulation Factor XI Market Size by Type (2027-2032)
  5. 7.2.3 North America Coagulation Factor XI Market Share by Type (2021-2032)
  6. 7.3 North America Coagulation Factor XI Market Size by Application
  7. 7.3.1 North America Coagulation Factor XI Market Size by Application (2021-2026)
  8. 7.3.2 North America Coagulation Factor XI Market Size by Application (2027-2032)
  9. 7.3.3 North America Coagulation Factor XI Market Share by Application (2021-2032)
  10. 7.4 North America Coagulation Factor XI Market Size by Country
  11. 7.4.1 North America Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Coagulation Factor XI Market Size by Country (2021-2026)
  13. 7.4.3 North America Coagulation Factor XI Market Size by Country (2027-2032)
  14. 7.4.4 North America Coagulation Factor XI Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Coagulation Factor XI Market Size (2021-2032)
  2. 8.2 Europe Coagulation Factor XI Market Size by Type
  3. 8.2.1 Europe Coagulation Factor XI Market Size by Type (2021-2026)
  4. 8.2.2 Europe Coagulation Factor XI Market Size by Type (2027-2032)
  5. 8.2.3 Europe Coagulation Factor XI Market Share by Type (2021-2032)
  6. 8.3 Europe Coagulation Factor XI Market Size by Application
  7. 8.3.1 Europe Coagulation Factor XI Market Size by Application (2021-2026)
  8. 8.3.2 Europe Coagulation Factor XI Market Size by Application (2027-2032)
  9. 8.3.3 Europe Coagulation Factor XI Market Share by Application (2021-2032)
  10. 8.4 Europe Coagulation Factor XI Market Size by Country
  11. 8.4.1 Europe Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Coagulation Factor XI Market Size by Country (2021-2026)
  13. 8.4.3 Europe Coagulation Factor XI Market Size by Country (2027-2032)
  14. 8.4.4 Europe Coagulation Factor XI Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Coagulation Factor XI Market Size (2021-2032)
  2. 9.2 China Coagulation Factor XI Market Size by Type
  3. 9.2.1 China Coagulation Factor XI Market Size by Type (2021-2026)
  4. 9.2.2 China Coagulation Factor XI Market Size by Type (2027-2032)
  5. 9.2.3 China Coagulation Factor XI Market Share by Type (2021-2032)
  6. 9.3 China Coagulation Factor XI Market Size by Application
  7. 9.3.1 China Coagulation Factor XI Market Size by Application (2021-2026)
  8. 9.3.2 China Coagulation Factor XI Market Size by Application (2027-2032)
  9. 9.3.3 China Coagulation Factor XI Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Coagulation Factor XI Market Size (2021-2032)
  2. 10.2 Asia Coagulation Factor XI Market Size by Type
  3. 10.2.1 Asia Coagulation Factor XI Market Size by Type (2021-2026)
  4. 10.2.2 Asia Coagulation Factor XI Market Size by Type (2027-2032)
  5. 10.2.3 Asia Coagulation Factor XI Market Share by Type (2021-2032)
  6. 10.3 Asia Coagulation Factor XI Market Size by Application
  7. 10.3.1 Asia Coagulation Factor XI Market Size by Application (2021-2026)
  8. 10.3.2 Asia Coagulation Factor XI Market Size by Application (2027-2032)
  9. 10.3.3 Asia Coagulation Factor XI Market Share by Application (2021-2032)
  10. 10.4 Asia Coagulation Factor XI Market Size by Country
  11. 10.4.1 Asia Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Coagulation Factor XI Market Size by Country (2021-2026)
  13. 10.4.3 Asia Coagulation Factor XI Market Size by Country (2027-2032)
  14. 10.4.4 Asia Coagulation Factor XI Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Coagulation Factor XI Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Coagulation Factor XI Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Coagulation Factor XI Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Coagulation Factor XI Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Coagulation Factor XI Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Coagulation Factor XI Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Coagulation Factor XI Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Coagulation Factor XI Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Coagulation Factor XI Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Coagulation Factor XI Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Coagulation Factor XI Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Coagulation Factor XI Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst